Multiprofessional Advance Care Planning and Shared Decision Making for End of Life Care (MAPS)
3 juni 2016 bijgewerkt door: University of Zurich
Multiprofessional Advance Care Planning and Shared Decision-making for End of Life Care MAPS Trial
Multiprofessional Advance Care Planning and shared decision making for end of live care for terminal patients and their relatives.
The aim of this study is to develop, implement and test a complex intervention for improving patients' preparation for and participation in end of life decisions. In cooperation with local, national and international partners, the investigators will focus on strategies to enhance advance care planning and shared decision making on end of life issues, and documentation and transferability of end of life decisions across health care settings in coordinated approach involving patients, their families and care givers (in and out of hospital).
Studie Overzicht
Toestand
Voltooid
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Werkelijk)
115
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
ZH
-
Zurich, ZH, Zwitserland, 8091
- University Hospital Zurich, Clinical Ethics
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion criteria: -patients in which the treating physician on the ward would not be surprised if the patient died during the next year (surprise question of Weissman et al 2011)
- male and female patients above 18 years of age
- signed informed consent after being informed
- patients able to appoint a surrogate decision maker (SM) and/or responsible physician to be contacted after discharge
Exclusion criteria: -patients not capable of speaking german
- patients having no responsible physician to be contacted after discharge and no relative/future surrogate decision maker (SM)
- inhouse patients being discharged within the next 2 days or ambulatory patients not regularly coming to the wards (at least every two month)
- patients assessed by their physician to be in obvious denial of their situation (illness/prognosis)
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verdrievoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Control Group
A routine care discharge planning with the social service
|
A routine care discharge planning with the social service
|
|
Experimenteel: Advance Care Planning ACP
Patient get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators. -------------------------------------------------------------------------------- |
Patient of the intervention group get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
end of life wish on resuscitation known (if alive) or fulfilled(if dead) after 6 month by responsible physician and/or surrogate decision maker (SM)
Tijdsspanne: during 2 weeks six months after discharge
|
during 2 weeks six months after discharge
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
end of live decisions on last place of care, antibiotics for pneumonia, feeding tube, intravenous fluids, dialysis, intubation and sedation,
Tijdsspanne: during 2 weeks six months after discharge
|
during 2 weeks six months after discharge
|
|
decisional conflict scale ("DCS"), O Connor et al 1995
Tijdsspanne: at discharge and during 2 Weeks six months after discharge
|
at discharge and during 2 Weeks six months after discharge
|
|
Satisfaction with information and care, (see Detering et al 2010)
Tijdsspanne: at discharge
|
at discharge
|
|
Hospital Anxiety and Depression scale ("HADS")
Tijdsspanne: discharge and during 2 weeks six months after discharge
|
discharge and during 2 weeks six months after discharge
|
|
Having an Advance directive
Tijdsspanne: at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
|
at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
|
|
Having an appointed surrogate decision maker
Tijdsspanne: at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge
|
at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge
|
|
Any hospital stay
Tijdsspanne: during 2 weeks three months after discharge and during 2 weeks six months after discharge
|
during 2 weeks three months after discharge and during 2 weeks six months after discharge
|
|
Decisions regarding end of life issues already having been made/taken place
Tijdsspanne: during 2 weeks six months after discharge
|
during 2 weeks six months after discharge
|
|
open question on important medical decisions being made
Tijdsspanne: during 2 weeks three months after discharge
|
during 2 weeks three months after discharge
|
|
Treatment against patients wishes
Tijdsspanne: during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death
|
during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death
|
|
Distress of Patients or relatives because of content of the consultation
Tijdsspanne: at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
|
at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Tanja Krones, MD, University Hospital Zurich, Clinical Ethics
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 juli 2013
Primaire voltooiing (Werkelijk)
1 april 2015
Studie voltooiing (Werkelijk)
1 augustus 2015
Studieregistratiedata
Eerst ingediend
26 november 2012
Eerst ingediend dat voldeed aan de QC-criteria
30 juli 2013
Eerst geplaatst (Schatting)
2 augustus 2013
Updates van studierecords
Laatste update geplaatst (Schatting)
6 juni 2016
Laatste update ingediend die voldeed aan QC-criteria
3 juni 2016
Laatst geverifieerd
1 juni 2016
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MAPS Trial
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .